Population
Patients with or at risk for coronary artery thrombosis, including unstable angina, acute myocardial…
Design
Review
Authors
Loading...
Supports expanded antiplatelet options beyond aspirin in coronary disease; leaves open optimal regimens and durations in contemporary practice.
This review provides an overview of the expanding options for antiplatelet therapy beyond aspirin for the management and prevention of coronary thrombosis.
Graaff et al. (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: